These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 34157802)

  • 1. [Value of Combined Detection of Cytokines and Tumor Markers in the 
Differential Diagnosis of Benign and Malignant Solitary Pulmonary Nodules].
    Shi J; Liu X; Ming Z; Li W; Lv X; Yang X; Wang Y; Zhang M; Yang S
    Zhongguo Fei Ai Za Zhi; 2021 Jun; 24(6):426-433. PubMed ID: 34157802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining serum miRNAs, CEA, and CYFRA21-1 with imaging and clinical features to distinguish benign and malignant pulmonary nodules: a pilot study : Xianfeng Li et al.: Combining biomarker, imaging, and clinical features to distinguish pulmonary nodules.
    Li X; Zhang Q; Jin X; Cao L
    World J Surg Oncol; 2017 May; 15(1):107. PubMed ID: 28545454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic value of serum tumor markers in differentiating malignant from benign solitary pulmonary nodules].
    Ni LF; Liu XM
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 46(5):707-10. PubMed ID: 25331391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic value of conventional tumor markers in young patients with pulmonary nodules.
    Xu L; Su Z; Xie B
    J Clin Lab Anal; 2021 Sep; 35(9):e23912. PubMed ID: 34296781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An evaluation of the tumour markers, carcinoembryonic antigen (CEA), cytokeratin marker (CYFRA 21-1) and neuron-specific enolase (NSE) in the differentiation of malignant from benign solitary pulmonary lesions.
    Seemann MD; Beinert T; Fürst H; Fink U
    Lung Cancer; 1999 Dec; 26(3):149-55. PubMed ID: 10598925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting malignant potential of solitary pulmonary nodules in patients with COVID-19 infection: a comprehensive analysis of CT imaging and tumor markers.
    Xiao H; Liu Y; Liang P; Hou P; Zhang Y; Gao J
    BMC Infect Dis; 2024 Sep; 24(1):1050. PubMed ID: 39333962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased levels of circulating sex hormones as a biomarker of lung cancer in male patients with solitary pulmonary nodules.
    Gu T; Wen Z; Xu S; Hua H; Zhang Z; Wen T; Fu Z; Lv X
    Afr Health Sci; 2014 Jun; 14(2):356-63. PubMed ID: 25320584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a plasma biomarker panel for discerning clinical significance of indeterminate pulmonary nodules.
    Daly S; Rinewalt D; Fhied C; Basu S; Mahon B; Liptay MJ; Hong E; Chmielewski G; Yoder MA; Shah PN; Edell ES; Maldonado F; Bungum AO; Borgia JA
    J Thorac Oncol; 2013 Jan; 8(1):31-6. PubMed ID: 23201823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combination of CTCs and CEA can help guide the management of patients with SPNs suspected of being lung cancer.
    Zheng J; Ye X; Liu Y; Zhao Y; He M; Xiao H
    BMC Cancer; 2020 Feb; 20(1):106. PubMed ID: 32041568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the discriminative methods for diagnosis of benign and malignant solitary pulmonary nodules based on serum markers.
    Wang W; Liu M; Wang J; Tian R; Dong J; Liu Q; Zhao X; Wang Y
    Oncol Res Treat; 2014; 37(12):740-6. PubMed ID: 25531720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of macrophage inhibitory cytokine-1 level in differentiating benign from malignant solitary pulmonary nodules.
    Xu CH; Xue JS; Zhang XW; Yu LK; Lin Y
    Clin Respir J; 2018 Apr; 12(4):1473-1478. PubMed ID: 28834599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel and convenient method to evaluate the character of solitary pulmonary nodule-comparison of three mathematical prediction models and further stratification of risk factors.
    Xiao F; Liu D; Guo Y; Shi B; Song Z; Tian Y; Liang C
    PLoS One; 2013; 8(10):e78271. PubMed ID: 24205175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Establishment and Verification of A Novel Predictive Model of Malignancy
for Non-solid Pulmonary Nodules].
    Xiao F; Yu Q; Zhang Z; Liu D; Liang C
    Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):26-33. PubMed ID: 30674390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combined diagnostic model based on circulating tumor cell in patients with solitary pulmonary nodules.
    Wang D; Li P; Fei X; Che S; Li J; Xuan Y; Wang J; Han Y; Gu W; Wang Y
    J Gene Med; 2023 Sep; 25(9):e3529. PubMed ID: 37194408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment and validation of a prediction model for the probability of malignancy in solid solitary pulmonary nodules in northwest China.
    Duan XQ; Wang XL; Zhang LF; Liu XZ; Zhang WW; Liu YH; Dong CH; Zhao XH; Chen L
    J Surg Oncol; 2021 Mar; 123(4):1134-1143. PubMed ID: 33497476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of peripheral blood rare cell EGFR gene amplification detection in the evaluation of benign and malignant pulmonary nodules].
    Li H; Liu XQ; Yan LJ; Liu Y; Zhang JQ; Xiao YN; Li SQ
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(18):1584-1589. PubMed ID: 38742345
    [No Abstract]   [Full Text] [Related]  

  • 17. Combined detection of serum IL-6 and CEA contributes to the diagnosis of lung adenocarcinoma
    Pan J; Zhuang W; Xia Y; Huang Z; Zheng Y; Wang X; Huang Y
    PeerJ; 2024; 12():e17141. PubMed ID: 38529301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of preoperative prediction factors of tumor subtypes for patients with solitary ground-glass opacity pulmonary nodules.
    Li M; Wang Y; Chen Y; Zhang Z
    J Cardiothorac Surg; 2018 Jan; 13(1):9. PubMed ID: 29343293
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers.
    Shen J; Liu Z; Todd NW; Zhang H; Liao J; Yu L; Guarnera MA; Li R; Cai L; Zhan M; Jiang F
    BMC Cancer; 2011 Aug; 11():374. PubMed ID: 21864403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
    Jiang ZF; Wang M; Xu JL
    Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.